Seaport Therapeutics, Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: SPTX
Seaport Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2024. Its shares trade on Nasdaq under the ticker SPTX. It has reported private securities offerings to the US SEC, most recently $226 million sold in a notice filed in 2024.
Seaport Therapeutics at a glance
What does Seaport Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $225.9 million sold (2024).
Frequently asked questions about Seaport Therapeutics
Where is Seaport Therapeutics headquartered?
Seaport Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Seaport Therapeutics do?
Seaport Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Seaport Therapeutics a public company?
Yes. Seaport Therapeutics, Inc. trades on Nasdaq under the ticker SPTX.
When was Seaport Therapeutics founded?
The earliest incorporation on record for Seaport Therapeutics, Inc. is in 2024, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.